(Q54562040)
Statements
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer. (English)
1 reference
Hope Rugo
1 reference
Erica L Mayer
1 reference
Jean-Francois Baurain
1 reference
Joseph Sparano
1 reference
Lewis Strauss
1 reference
Mario Campone
1 reference
Pierre Fumoleau
1 reference
Ahmad Awada
1 reference
Oumar Sy
1 reference
Antonio Llombart-Cussac
1 reference
8 September 2011
1 reference
17
1 reference
6897-6904
1 reference
21
1 reference
Identifiers
1 reference